Bonus Biogroup Ltd.是一家生物科技公司,從事幹細胞與組織工程領域。該公司正開發基於自體與同種異體骨移植的細胞治療產品,將有助於有效的骨移植,並提供以細胞為基礎的骨替代假體來修復骨損傷。該公司的目標市場為全球,針對主要疾病如骨骼與軟骨相關的關節炎、骨質疏鬆症,以及各種類型的骨骼與關節創傷,例如髖部骨折與膝蓋受傷等。2012年4月29日,Bonus Bio Group Ltd.全面收購了Bonus Therapeutic Ltd.
BBIXF stock price ended at $0.15 on 星期三, after rising 50.00%
On the latest trading day Feb 11, 2026, the stock price of BBIXF rose by 50.00%, climbing from $0.15 to $0.15. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.15 and a high of $0.15. Alongside this price increase, trading volume also rose by 17.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 500 shares were traded, amounting to a market value of approximately --.